RxDoctor Payments Data

Eli Silver, MD

Dermatology · Napa, CANPI 1245581123

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Amgen at 47.0% of the total. Reporting peaked in 2022 at $382 and has fallen 64.6% since, to $135 in 2024. That places this record below the midpoint for dermatology clinicians in CA, where the typical reported total is $1,655.

$778in general payments, 2019–2025

Across 13 payments — averaging $59.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$366
  • Stemline Therapeutics Inc.$114
  • AbbVie$112
  • Pfizer$72
  • Kyowa Kirin, Inc.$36
  • UCB, Inc.$33
  • plus $46 from 2 others

What the payments were for

  • Food & beverage$74295%
  • Education$365%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$778 in reported general payments places this provider in the 35th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$81,712
Medicare patients
90
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin17$118

Paid to pharmacies, not to this prescriber.

Other dermatology in Napa

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →